Synthetic Growth Hormone-Releasing Hormone Agonist Ameliorates the Myocardial Pathophysiology Characteristic of HFpEF

Researchers demonstrated that the activation of the growth hormone-releasing hormone receptor signaling pathway within the myocardium both prevented and reversed diastolic dysfunction and pathophysiologic features consistent with heart failure with preserved ejection fraction (HFpEF).